What is the Projected CAGR value of the 3D Printed Drugs Market?
The 3D Printed Drugs Market is expected to grow at a CAGR of 8.10% during the forecast period 2024-2031
Who are the key players in 3D Printed Drugs Market?
Key players are Aprecia Pharmaceuticals, GlaxoSmithKline Plc., Hewlett Packard Caribe, BV, LLC and FabRx Ltd.